We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hemoglobin A1c Preferred to Glucose for Diabetes Diagnosis

By LabMedica International staff writers
Posted on 27 Jul 2009
Hemoglobin A1c (HbA1c) was an accepted and reliable measure of long-term glycemic control in diabetics, whereas glucose has been the "gold standard” for diabetes diagnosis. More...
Chemical societies and laboratories have to deal with a surprising recommendation to measure HbA1c rather than glucose for diagnosis of diabetes.

The new recommendation was discussed at the American Association for Clinical Chemistry's (AACC) 2009 annual meeting, which was held in Chicago, IL, (USA) from July 19-23, 2009. A seminar at the meeting focused on the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) criteria for screening and diagnosing diabetes; the ADA criteria for diagnosing diabetes in pregnant women; and the use of handheld glucose meters in intensive care unit (ICU) patients.

Dr. David B. Sacks, from Brigham and Women's Hospital (Boston, MA, USA), reported that the new recommendation to measure HbA1c rather than glucose for diagnosis of diabetes is a major departure from all prior guidelines. He said, "Although the specific details of the recommendations to be proposed by these bodies have not been decided, it appears highly likely that all of the major clinical diabetes organizations will adopt HbA1c measurement for the diagnosis of diabetes.”

Related Links:

Brigham and Women's Hospital



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Hematology Consumables
Bioblood Devices
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.